Policy / Regulatory

NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities

CompanyDrug

Bio-Thera Solutions’ BAT8010 Receives NMPA Approval for Solid Tumor Clinical Trials

CompanyDrug

Kelun Pharma’s SKB264 ADC Receives Breakthrough Therapy Designation for TNBC

CompanyR&D

Burning Rock Biotech Launches PREVENT Study for Early Cancer Detection

CompanyDeals

Harbour BioMed’s Partner NK Celltech Raises RMB 100M in Series A Financing

Policy / Regulatory

NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation

CompanyDrug

BeiGene’s Tislelizumab Shows Survival Benefit in Esophageal Cancer Study

Policy / Regulatory

NMPA Releases Work Plans for Temporary Import of Urgently Needed Drugs

CompanyDrug

Huadong Medicine’s Biosimilar Ozempic (Semaglutide) Wins NMPA Clinical Trial Approval

Drug

Jixing Pharmaceuticals Enrolls First Patient in Etripamil Phase III Study for PSVT

CompanyDrug

Takeda’s Obizur Prioritized for Review in Acquired Hemophilia A Treatment